Table III.

Multivariate model of the relationship of sociodemographic and clinical factors to 60-day mortality in hospitalized acute myeloid leukaemia patients receiving chemotherapy, California 1999–2012.

Variable	Odds Ratio	(95% confidence interval)	P-value
Gender
Female vs Male	0.91	(0.78, 1.06)	0.213
Age (years)
15–39 vs >66	0.11	(0.08, 0.16)	<0.0001
40–54 vs >66	0.20	(0.16, 0.26)	<0.0001
55–65 vs >66	0.32	(0.26, 0.40)	<0.0001
Race/Ethnicity
Asian vs Non-Hispanic White	0.81	(0.64, 1.04)	0.094
Hispanic vs Non-Hispanic White	0.82	(0.66, 1.01)	0.064
African American vs Non-Hispanic White	0.66	(0.46, 0.94)	0.022
Year of diagnosis
2003–2006 vs 1999–2002	0.66	(0.54, 0.80)	<0.0001
2007–2009 vs 1999–2002	0.50	(0.40, 0.61)	<0.0001
2010–2012 vs 1999–2002	0.38	(0.30, 0.47)	<0.0001
Marital status at diagnosis
Single marital status vs Married	1.25	(1.07, 1.46)	0.006
Neighbourhood Socioeconomic status
Low vs High	1.21	(1.03, 1.41)	0.017
Health insurance status
Medicare vs Private insurance	1.07	(0.88, 1.30)	0.519
Public insurance vs Private insurance	1.08	(0.81, 1.44)	0.585
Uninsured vs Private insurance	2.44	(1.45, 4.13)	<0.001
Comorbidities
1–2 comorbidities vs 0 comorbidities	1.46	(1.16, 1.84)	0.001
3+ comorbidities vs 0 comorbidities	1.97	(1.56, 2.49)	<0.0001
Bleeding vs none	1.54	(1.56, 1.88)	<0.0001
Sepsis vs none	1.05	(0.89, 1.23)	0.568
Thrombosis vs none	0.85	(0.50, 1.46)	0.563
Liver failure vs none	1.87	(1.12, 3.12)	0.017
Renal failure vs none	2.39	(2.00, 2.86)	<0.0001
Respiratory failure vs none	7.59	(6.18, 9.33)	<0.0001
Cardiac arrest vs none	15.79	(8.73, 28.56)	<.00001
Hospital type
Kaiser vs Private	0.91	(0.73, 1.14)	0.410
NCI-designated vs Private	0.45	(0.36, 0.56)	<0.0001
Teaching vs Private	0.92	(0.72, 1.19)	0.536
Leukapheresis vs none	1.26	(0.85, 1.86)	0.256

NCI-designated=National Cancer Institute designated cancer centre